ArticleActa oncologica (Stockholm, Sweden)2024

Baseline neutrophil-to-eosinophil-ratio and outcome in metastatic clear-cell renal cell carcinoma treated with nivolumab or ipilimumab/nivolumab.

Yana Beulque et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.